Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, UNITED STATES
Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist metabolism program
Norwood, MA, Jan. 20, 2021 (GLOBE NEWSWIRE) Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced it will participate in the New York Academy of Sciences’
webinar on January 27, 2021 on the endocannabinoid system as a target for therapeutic agents.
Long Island has 41 scholars in Regeneron science competition newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.
>Pandemic Villains: Robinhood Matt Taibbi
I never heard of Robinhood nor do I use Facebook (though I do use WhatsApp to stay in touch with family) but “selling intelligence about customers’ behaviors to experts” seems to be an extension of what Snowden revealed the gov’t was doing. In this instance, as in Facebook, people will voluntarily flock to a product that is free and think little of their privacy. An individual giving up her privacy when she has nothing to hide may seem innocuous enough, when a whole society thinks the same I can only imagine what the dystopic outcome will be given how power tends to corrupt in proportion to its increase.